Yongtao Han

机构：University of Electronic Science and Technology of China, Ruijin Hospital, Sichuan Cancer Hospital · ORCID：0000-0002-9109-6014

发表论文 67 篇 · 总被引 2216 次 · h-index 18

代表论文

• Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China (2022 · Diseases of the Esophagus · 被引 42)
• The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis (2023 · Frontiers in Immunology · 被引 36)
• Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010 (2022 · Journal of Thoracic and Cardiovascular Surgery · 被引 26)
• Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial (2024 · Nature Communications · 被引 24)
• Chemotherapy plus camrelizumab versus chemotherapy alone as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (ESCORT-NEO): A multi-center, randomized phase III trial. (2024 · Journal of Clinical Oncology · 被引 15)
• Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring (2025 · Molecular Cancer · 被引 13)